Characterization Data on the Topical Carrier DDC642
Overview
Authors
Affiliations
This article contains original data, figures and methods used in the characterization of the liposomal carrier 'DDC642' for topical applications, described in "An elastic liposomal formulation for RNAi-based topical treatment of skin disorders: proof-of-concept in the treatment of psoriasis" (Desmet et al., 2016) [1]. Several elastic liposomal formulations have been evaluated for their ability to encapsulate and deliver RNA interference (RNAi) molecules to cultured primary skin cells. The efficiency and effectiveness of these liposomes were compared to that of our previously characterized liposomes, the 'SECosomes' (SEC) (Geusens et al., 2010) [2]. After selection of a potential superior carrier, based on encapsulation and transfection efficiency data (Desmet et al., 2016) [1], the selected DDC642 liposomes were characterized more in-depth. Herein, a detailed characterization of the DDC642 liposome and RNAi-loaded lipoplexes is given, including the matching protocols.
Editing via RNA -Splicing in RDEB-Derived Skin Equivalents.
Liemberger B, Bischof J, Ablinger M, Hainzl S, Murauer E, Lackner N Int J Mol Sci. 2023; 24(5).
PMID: 36901775 PMC: 10002491. DOI: 10.3390/ijms24054341.
Ablinger M, Lettner T, Friedl N, Potocki H, Palmetzhofer T, Koller U Int J Mol Sci. 2021; 22(7).
PMID: 33805154 PMC: 8036626. DOI: 10.3390/ijms22073326.
Advances in the Application and Impact of MicroRNAs as Therapies for Skin Disease.
Lawrence P, Ceccoli J BioDrugs. 2017; 31(5):423-438.
PMID: 28875300 PMC: 5610219. DOI: 10.1007/s40259-017-0243-4.